Novartis Investigative Site

Snellville, Georgia 30078

0 studies enrolling now · 6 studies all time

What they study most

Chronic Plaque-type Psoriasis, Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris, Moderate to Severe Chronic Plaque-type Psoriasis, Moderate to Severe Plaque-type Psoriasis, Plaque-type Psoriasis

Studies at this site

• PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus — Completed
• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis — Completed
• Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis — Completed
• AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis — Completed